Cargando...
The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada
BACKGROUND: Patient reported outcome measures (PROMs) and minimal clinically important differences (MCIDs) are included in Canada’s Common Drug Review (CDR) process to approve new drugs. Often, the measures report on the health-related quality of life (HRQoL), but can also describe the symptoms, eff...
Gardado en:
| Publicado en: | Health Qual Life Outcomes |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6322322/ https://ncbi.nlm.nih.gov/pubmed/30616654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12955-018-1070-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|